南京医药(600713.SH)上半年归母净利润同比增长28.76%至2.22亿元_老虎社区_美港股上老虎

南京医药(600713.SH)上半年归母净利润同比增长28.76%至2.22亿元

智通财经2021-08-20

智通财经APP讯，南京医药(600713.SH)发布2021年半年度报告，该公司期内营业收入218.97亿元，同比增长19.84%。归属于上市公司股东的净利润2.22亿元，同比增长28.76%。归属于上市公司股东的扣除非经常性损益的净利润2.2亿元，同比增长69.29%。基本每股收益0.213元。2021年上半年，公司坚持疫情防控和经营发展“两手抓”，一方面根据南京市政府及国资控股股东的部署要求，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

tetehao红茶
·2021-08-21
涨停
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2160715853?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/e0ab8365ea89ee143187cbf51d23ba8f","is_english":false,"pubTime":"2021-08-20 17:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2160715853","market":"hk","top_or_hot":-1,"title":"南京医药(600713.SH)上半年归母净利润同比增长28.76%至2.22亿元","media":"智通财经","content":"<div>\n<p>智通财经APP讯，南京医药(600713.SH)发布2021年半年度报告，该公司期内营业收入218.97亿元，同比增长19.84%。归属于上市公司股东的净利润2.22亿元，同比增长28.76%。归属于上市公司股东的扣除非经常性损益的净利润2.2亿元，同比增长69.29%。基本每股收益0.213元。2021年上半年，公司坚持疫情防控和经营发展“两手抓”，一方面根据南京市政府及国资控股股东的部署要求，...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/540152.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>南京医药(600713.SH)上半年归母净利润同比增长28.76%至2.22亿元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n南京医药(600713.SH)上半年归母净利润同比增长28.76%至2.22亿元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-20 17:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/540152.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，南京医药(600713.SH)发布2021年半年度报告，该公司期内营业收入218.97亿元，同比增长19.84%。归属于上市公司股东的净利润2.22亿元，同比增长28.76%。归属于上市公司股东的扣除非经常性损益的净利润2.2亿元，同比增长69.29%。基本每股收益0.213元。2021年上半年，公司坚持疫情防控和经营发展“两手抓”，一方面根据南京市政府及国资控股股东的部署要求，...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/540152.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600713","symbol_name":"南京医药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/540152.html","article_id":"2160715853","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/e0ab8365ea89ee143187cbf51d23ba8f"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2160715853","pubTimestamp":1629450023,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，南京医药 发布2021年半年度报告，该公司期内营业收入218.97亿元，同比增长19.84%。归属于上市公司股东的净利润2.22亿元，同比增长28.76%。基本每股收益0.213元。报告期内，营业收入变动主要是公司报告期营业收入较上期增加主要系公司本期销售增长所致。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"600713":"南京医药"},"translate_title":"Nanjing Pharmaceutical (600713. SH) 's net profit attributable to its mother in the first half of the year increased by 28.76% year-on-year to 222 million yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600713":1},"content_text":"智通财经APP讯，南京医药(600713.SH)发布2021年半年度报告，该公司期内营业收入218.97亿元，同比增长19.84%。归属于上市公司股东的净利润2.22亿元，同比增长28.76%。归属于上市公司股东的扣除非经常性损益的净利润2.2亿元，同比增长69.29%。基本每股收益0.213元。2021年上半年，公司坚持疫情防控和经营发展“两手抓”，一方面根据南京市政府及国资控股股东的部署要求，全力做好疫情防控物资保供及常态化疫情防控工作;另一方面积极应对行业“白热化”的竞争形势，主营业务保持稳中有进势头，各项目标任务继续扎实有序推进。报告期内，营业收入变动主要是公司报告期营业收入较上期增加主要系公司本期销售增长所致。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":836236838,"gmtCreate":1629497711524,"gmtModify":1629497711524,"author":{"id":"3534470103714641","authorId":"3534470103714641","name":"tetehao红茶","avatar":"https://static.tigerbbs.com/0e0e0b8c1a6d1c31e25f5e6875d70445","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"涨停","listText":"涨停","text":"涨停","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/836236838","repostId":2160715853,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}